Protein level of apolipoprotein E increased in human hepatocellular carcinoma

International Journal of Oncology

Volumn 28, Issue 3, 2006, Pages 625-631

  Yokoyama, Yuichiro ^a   Kuramitsu, Yasuhiro ^a   Takashima, Motonari ^a   Iizuka, Norio ^a   Terai, Shuji ^a   Oka, Masaaki ^a   Nakamura, Kazuyuki ^a   Okita, Kiwamu ^a   Sakaida, Isao ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apolipoprotein E; Hepatocellular carcinoma; O linked glycoprotein

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED;

ADULT; AGED; APOLIPOPROTEINS E; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 33645213047     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.3.625     Document Type: Article

References (43)

1. Park KS, Cho SY, Kim H and Paik YK: Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int J Cancer 97: 261-265, 2002.
2. Park KS, Kim H, Kim NG, Cho SY, Choi KH, Seong JK and Paik YK: Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma. Hepatology 35: 1459-1466, 2002.
3. Kim J, Kim SH, Lee SU, et al: Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 23: 4142-4156, 2002.
4. Lim SO, Park SJ, Kim W, et al: Proteome analysis of hepatocellular carcinoma. Biochem Biophys Res Commun 291: 1031-1037, 2002.
5. Tannapfel A, Anhalt K, Hausermann P, et al: Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J Pathol 201: 238-249, 2003.
6. Takashima M, Kuramitsu Y, Yokoyama Y, et al: Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 3: 2487-2493, 2003.
7. Yokoyama Y, Kuramitsu Y, Takashima M, et al: Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 4: 2111-2116, 2004. (Pubitemid 38880376)
8. Kim W, Oe Lim S, Kim JS, et al: Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma. Clin Cancer Res 9: 5493-5500, 2003.
9. Ohata K, Hamasaki K, Toriyama K, et al: Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97: 3036-3043, 2003.
10. Moriya K, Fujie H, Shintani Y, et al: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4: 1065-1067, 1998.
11. Lerat H, Honda M, Beard MR, et al: Steatosis and liver cancer in transgenic mice expressing the structural and non-structural proteins of hepatitis C virus. Gastroenterology 122: 352-365, 2002.
12. Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G and Day CP: Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastro-enterology 126: 586-597, 2004.
13. Thomssen R, Bonk S, Propfe C, Heermann KH, Kochel HG and Uy A: Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol 181: 293-300, 1992.
14. Monazahian M, Bohme I, Bonk S, Koch A, Scholz C, Grethe S and Thomssen R: Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol 57: 223-229, 1999.
15. Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR and Lai MM: Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292: 198-210, 2002.
16. Sabile A, Perlemuter G, Bono F, et al: Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 30: 1064-1076, 1999.
17. Perlemuter G, Sabile A, Letteron P, et al: Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 16: 185-194, 2002.
18. Serfaty L, Andreani T, Giral P, Carbonell N, Chazouilleres O and Poupon R: Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 34: 428-434, 2001.
19. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630, 1988.
20. Venanzoni MC, Giunta S, Muraro GB, et al: Apolipoprotein E expression in localized prostate cancers. Int J Oncol 22: 779-786, 2003.
21. Oue N, Hamai Y, Mitani Y, et al: Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 64: 2397-2405, 2004.
22. Chen YC, Pohl G, Wang TL, et al: Apolipoprotein E is required for cell proliferation and survival in ovarian cancer. Cancer Res 65: 331-337, 2005.
23. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC and Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646-649, 1973.
24. Kudo M, Chung H and Osaki Y: Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38: 207-215, 2003.
25. Iizuka N, Oka M, Yamada-Okabe H, et al: Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 62: 3939-3944, 2002.
26. Zannis VI, van der Spek J and Silverman D: Intracellular modifications of human apolipoprotein E. J Biol Chem 261: 13415-13421, 1986.
27. Zannis VI, Kurnit DM and Breslow JL: Hepatic apo-A-I and apo-E and intestinal apo-A-I are synthesized in precursor isoprotein forms by organ cultures of human fetal tissues. J Biol Chem 257: 536-544, 1982.
28. Kuipers F, van Ree JM, Hofker MH, et al: Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver. Hepatology 24: 241-247, 1996.
29. Mensenkamp AR, Havekes LM, Romijn JA and Kuipers F: Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E. J Hepatol 35: 816-822, 2001.
30. Mensenkamp AR, van Luyn MJ, Havinga R, et al: The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice. J Hepatol 40: 599-606, 2004.
31. Mensenkamp AR, Teusink B, Baller JF, et al: Mice expressing only the mutant APOE3Leiden gene show impaired VLDL secretion. Arterioscler Thromb Vasc Biol 21: 1366-1372, 2001.
32. Brahimi F, Bertrand P, Starck M, Galteau MM and Siest G: Control of apolipoprotein E secretion in the human hepatoma cell line KYN-2. Cell Biochem Funct 19: 51-58, 2001.
33. Forte TM, McCall MR, Knowles BB and Shore VG: Isolation and characterization of lipoproteins produced by human hepatoma-derived cell lines other than HepG2. J Lipid Res 30: 817-829, 1989.
34. Babin PJ, Thisse C, Durliat M, Andre M, Akimenko MA and Thisse B: Both apolipoprotein E and A-I genes are present in a non-mammalian vertebrate and are highly expressed during embryonic development. Proc Natl Acad Sci USA 94: 8622-8627, 1997.
35. Liu DY, Peng ZH, Qiu GQ and Zhou CZ: Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis. World J Gastroenterol 9: 1859-1862, 2003.
36. Pan M, Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ and Fisher EA: Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest 113: 1277-1287, 2004.
37. Quinn CM, Kagedal K, Terman A, Stroikin U, Brunk UT, Jessup W and Garner B: Induction of fibroblast apolipoprotein E expression during apoptosis, starvation-induced growth arrest and mitosis. Biochem J 378: 753-761, 2004.
38. Wernette-Hammond ME, Lauer SJ, Corsini A, Walker D, Taylor JM and Rall SC Jr: Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. J Biol Chem 264: 9094-9101, 1989.
39. Zannis VI, McPherson J, Goldberger G, Karathanasis SK and Breslow JL: Synthesis, intracellular processing, and signal peptide of human apolipoprotein E. J Biol Chem 259: 5495-5499, 1984.
40. Raval GN, Patel DD, Parekh LJ, Patel JB, Shah MH and Patel PS: Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer. Oral Dis 9: 119-128, 2003.
41. Wang PH, Lee WL, Lee YR, et al: Enhanced expression of alpha 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma. Gynecol Oncol 89: 395-401, 2003.
42. Lin S, Kemmner W, Grigull S and Schlag PM: Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Exp Cell Res 276: 101-110, 2002.
43. Dall'Olio F, Chiricolo M, D'Errico A, Gruppioni E, Altimari A, Fiorentino M and Grigioni WF: Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis. Glycobiology 14: 39-49, 2004.